Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IQV · NYSE · Life Sciences Tools & Services
IQVIA (IQV) · oqro.io/stocks/IQV · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of IQVIA was filed in the last 90 days. The latest on record was on Feb 8, 2025.
Since 2013, IQVIA insiders reported 7 open-market purchases and 243 sales on Forms 4 and 5, with purchases in 4 different years, most recently 2024.
In the last 90 days, 2 insiders of IQVIA (IQV) reported 2 open-market sales worth $1.94M in total on SEC Form 4. The largest seller by value was Eric Sherbet, with $1.24M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 5 trades in IQVIA (IQV) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Kevin Hern (OK01), Sen. Markwayne Mullin.
IQVIA's next results are expected on Feb 3, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$257.84+0.24 (+0.09%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
+18.7% (+$40.56) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $217.28 on Nov 18, 2025 to $257.84 on Nov 18, 2026 (+18.7%). Disclosed in this range: 11 insider trades, 0 pre-arranged insider sales, 5 Congress trades, and 68 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Life Sciences Tools & Services company based in Durham, North Carolina.
Last 12 months
+18.7%
Market value
$42.5B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 3.04M shares sold short (1.8% of shares outstanding), +1.7% vs the previous count, 2.1 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$4.43B
+8.0% vs the same quarter a year earlier
Free cash flow, last 12 months
$2.08B
This quarter $667M, a year earlier $772M
Net debt
$13.8B
Debt $16.1B, cash $2.25B, at Sep 30, 2026
Backlog
$34.2B
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 27, 2026.
Revenue, fiscal 2025
$16.3B
+5.9% vs the year before
Net income, fiscal 2025
$1.36B
As reported in the annual filing
Shares outstanding
165M
As of Oct 20, 2026
In fiscal 2025 the company spent $1.24B buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 9 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −7.5% · S&P 500 −3.0% · to Nov 18
IQVIA's See Remarks sold $1.24M of IQVIA shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 9 · filed the same day
An IQVIA officer told the SEC about a plan to sell $1.24M of IQVIA shares around Nov 9, 2026. The shares were not acquired as compensation.
Traded Sep 8 – Sep 14, 2026 · disclosed 11 to 17 days later · largest single trade $15,001–$50,000Sits on House Ways and Means, Health
Sep 14, 2026$15,001–$50,000Joint
DetailsOfficial recordSep 8, 2026$1,001–$15,000Dependent child
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Written by software from the filings listed below · Oct 19, 2026
4 more points, with the facts they come from, are in OQRO Pro.
Sign up freeOn the public record for IQVIA over the 12 months to Nov 18, 2026: 6 executive contributions.
Insiders of IQVIA reported 7 open-market purchases and 243 sales since 2013; purchases in 4 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $31.1M10×10 trades |
| 2025 | — | $22.7M10×10 trades |
| 2024 | $256K1×1 trade | $17.4M13×13 trades |
| 2023 | — | $10.9M10×10 trades |
| 2021 | $2.73M3×3 trades | $147M3×3 trades |
| 2020 | $12.8M2×2 trades | $1.16B21×21 trades |
| 2019 | — | $1.27B19×19 trades |
| 2018 | — | $2.08B33×33 trades |
| 2017 | — | $3.52B35×35 trades |
| 2016 | $33K1×1 trade | $157M11×11 trades |
| 2015 | — | $2.05B22×22 trades |
| 2014 | — | $3.13B38×38 trades |
| 2013 | — | $781M18×18 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Top officer leaving
“Bruehlman will retire, effective February 28, 2026, from his current role as Executive Vice President and Chief Financial Officer and transition to Senior Advisor to the CEO, ensuring continuity and a seamless transition.”
2 insiders sold ~$1.21M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
People read IQVIA's Wikipedia article about 180 times a day over the last week, close to the 210 on a usual day of the three months before.
May 14, 2026Busiest day: 380 views on Sep 25, 2026Nov 18, 2026
Views of the article IQVIA, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
Recent moves
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
66 certified in FY2026 Q3, vs 64 a year earlier. 66 positions in total, median offered wage $140K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Last results
Oct 27, 2026
Within the 30 days after it, until Nov 26, 2026
Next results, expected
Feb 3, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From IQVIA's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know IQVIA's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Short sale volume: 40.3% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 48.4%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 3,661 shares (about $1.02M) were not delivered on time for settlement on Oct 23, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 46.4% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (34.2% on ATS, 12.2% with other brokers), close to its 26-week average of 45.1%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: SIGMA X2 (13.2%), UBS ATS (12.7%), INTELLIGENT CROSS LLC (12.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Latest annual report filed Feb 17, 2026, compared with the one filed Feb 13, 2025. Read the filing
Information pertaining to legal proceedings can be found in Note 12 to our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K and is incorporated by reference herein.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 17, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Attention
Things to keep in mind
Against the S&P 500 over the year
Since Nov 17, 2025, IQV is up 19.3% and the index fund is up 9.7%: 10 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much IQV moves
Beta 0.7 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).